HEPATITIS B CHRONIC
Clinical trials for HEPATITIS B CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS B CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims for functional cure in hepatitis b
Disease control Not yet recruitingThis phase 2 study tests whether the drug bepirovirsen can achieve a functional cure for chronic hepatitis B in 30 adults with low virus levels. Participants receive weekly injections for 24 weeks and undergo liver biopsies to measure changes in the virus and immune response. The…
Matched conditions: HEPATITIS B CHRONIC
Phase: PHASE2 • Sponsor: National University Health System, Singapore • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New injection aims to tame chronic hepatitis b
Disease control Not yet recruitingThis early-phase study tests a new injectable drug called AHB-171 in 144 adults with chronic hepatitis B. The main goals are to check the drug's safety and how the body processes it. Some participants will also take standard oral antivirals. The study is not yet recruiting.
Matched conditions: HEPATITIS B CHRONIC
Phase: PHASE1 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can an immune booster keep liver cancer away after surgery?
Disease control Not yet recruitingThis early-phase study will test whether adding peginterferon alfa-2b to standard antiviral drugs can help prevent hepatitis B-related liver cancer from coming back after surgery. About 156 adults aged 18 to 65 will receive either the combination or antivirals alone. Researchers …
Matched conditions: HEPATITIS B CHRONIC
Phase: EARLY_PHASE1 • Sponsor: Ningbo No.2 Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a herbal capsule slash liver cancer risk in hepatitis b patients?
Disease control Not yet recruitingThis study tests whether adding Babao Dan Capsule (a traditional Chinese medicine) to standard antiviral treatment can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis who are at high risk. About 1,034 adults aged 18-65 with a specific TCM …
Matched conditions: HEPATITIS B CHRONIC
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Herbal compound may cut liver cancer risk in High-Risk hepatitis b patients
Disease control Not yet recruitingThis study tests whether adding a traditional Chinese medicine called Biejia-Ruangan compound to standard antiviral therapy can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis. About 1,034 high-risk adults (based on a special score) will b…
Matched conditions: HEPATITIS B CHRONIC
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Stick-On ultrasound patch could spot liver damage without a specialist
Diagnosis Not yet recruitingThis study tests a new wearable patch-type ultrasound probe that sticks to the skin over the liver to measure stiffness, which can indicate scarring (fibrosis) or cirrhosis. Researchers will compare its accuracy to the standard FibroScan device in 150 adults with chronic liver di…
Matched conditions: HEPATITIS B CHRONIC
Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
New study aims to outsmart hepatitis b drug resistance
Knowledge-focused Not yet recruitingThis study looks at how the hepatitis B virus changes over time in people taking antiviral drugs. Researchers will analyze blood samples from 700 adults in Turkey to see if the virus becomes resistant to treatment. The goal is to help doctors choose the best medications for each …
Matched conditions: HEPATITIS B CHRONIC
Sponsor: Yaşar Bayındır, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Handheld scanner could make liver checks easier
Knowledge-focused Not yet recruitingThis study will compare a new handheld device to the standard iLivTouch system for measuring liver stiffness and fat in 224 adults with chronic liver disease. Participants will be tested with both devices while lying down and sitting. The goal is to see if the handheld device is …
Matched conditions: HEPATITIS B CHRONIC
Sponsor: Hong You • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC